Since 1 January 2021, Intravacc is an independent public shareholding company, the State of the Netherlands being the sole shareholder. All members of Intravacc’s Supervisory Board have an outstanding track record at senior management level, both in the healthcare and pharmaceutical industries. Under the supervision of the Supervisory Board, Intravacc can further professionalise and develop into a full-fledged Contract Development & Manufacturing Organization.